VIDEO – ‘Three D’ for hepatitis C called ‘revolutionary’

CHICAGO – An experimental triple-drug regimen with or without ribavirin cured more than 90% of 724 previously untreated patients with hepatitis C genotype 1 who did not have cirrhosis.

And it was...